Credit Suisse’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-165,770
| Closed | -$35K | – | 3711 |
|
|
2018
Q1 | $35K | Buy |
165,770
+47,000
| +40% | +$9.92K | ﹤0.01% | 3479 |
|
|
2017
Q4 | $153K | Sell |
118,770
-124,099
| -51% | -$160K | ﹤0.01% | 3295 |
|
|
2017
Q3 | $515K | Buy |
242,869
+8,326
| +4% | +$17.7K | ﹤0.01% | 3040 |
|
|
2017
Q2 | $680K | Sell |
234,543
-197
| -0.1% | -$571 | ﹤0.01% | 2573 |
|
|
2017
Q1 | $808K | Sell |
234,740
-23,612
| -9% | -$81.3K | ﹤0.01% | 2669 |
|
|
2016
Q4 | $449K | Sell |
258,352
-5,585
| -2% | -$9.71K | ﹤0.01% | 3145 |
|
|
2016
Q3 | $877K | Buy |
+263,937
| New | +$877K | ﹤0.01% | 2743 |
|
|
2016
Q2 | – | Sell |
-260,997
| Closed | -$1.47M | – | 4071 |
|
|
2016
Q1 | $1.47M | Buy |
260,997
+13,472
| +5% | +$75.8K | ﹤0.01% | 2181 |
|
|
2015
Q4 | $4.26M | Sell |
247,525
-132,980
| -35% | -$2.29M | ﹤0.01% | 1574 |
|
|
2015
Q3 | $8.03M | Sell |
380,505
-21,459
| -5% | -$453K | 0.01% | 1165 |
|
|
2015
Q2 | $19.9M | Buy |
401,964
+303,713
| +309% | +$15M | 0.02% | 775 |
|
|
2015
Q1 | $7.69M | Buy |
98,251
+41,721
| +74% | +$3.27M | 0.01% | 1225 |
|
|
2014
Q4 | $3.43M | Sell |
56,530
-68,527
| -55% | -$4.15M | ﹤0.01% | 1814 |
|
|
2014
Q3 | $5.33M | Buy |
125,057
+53,540
| +75% | +$2.28M | ﹤0.01% | 1475 |
|
|
2014
Q2 | $4.42M | Buy |
71,517
+43,457
| +155% | +$2.69M | ﹤0.01% | 1768 |
|
|
2014
Q1 | $1.82M | Sell |
28,060
-8,531
| -23% | -$555K | ﹤0.01% | 2286 |
|
|
2013
Q4 | $2.06M | Buy |
36,591
+25,132
| +219% | +$1.42M | ﹤0.01% | 2259 |
|
|
2013
Q3 | $703K | Buy |
11,459
+4,257
| +59% | +$261K | ﹤0.01% | 2846 |
|
|
2013
Q2 | $422K | Buy |
+7,202
| New | +$422K | ﹤0.01% | 3037 |
|